[Bioregulatory drug Newrexan in the treatment of anxiety and dissomnia. Resolution of the Council of Experts (June 8, 2023)].

Autor: Barantsevich ER; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Kurushina OV; Volgograd State Medical University, Volgograd, Russia., Akhmadeeva LR; Bashkir State Medical University, Ufa, Russia., Skoromets AP; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Belova AN; Volga Research Medical University, Nizhny Novgorod Russi, Volga Research Medical University, Nizhny Novgorod Russia., Mendelevich EG; Kazan State Medical University, Kazan, Russia., Kovalchuk VV; Semashko City Hospital No. 38, St. Petersburg, Russia., Doronina OB; Sibneiromed, Novosibirsk, Russia., Barkhatov MV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Kamchatnov PR; Pirogov Russian National Research Medical University, Moscow, Russia.
Jazyk: ruština
Zdroj: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (7), pp. 143-146.
DOI: 10.17116/jnevro2023123071143
Abstrakt: Bioregulatory drug Newrexan in the treatment of anxiety and dissomnia. Resolution of the Council of Experts.
Databáze: MEDLINE